Related references
Note: Only part of the references are listed.The blood-brain barrier: Physiology and strategies for drug delivery
Rucha Pandit et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors
Heike Biebermann et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2020)
Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6
Lorenza Bellusci et al.
MOLECULES (2020)
Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity
Alice Accorroni et al.
THYROID (2020)
Endocrine, Metabolic and Pharmacological Effects of Thyronamines (TAM), Thyroacetic Acids (TA) and Thyroid Hormone Metabolites (THM) - Evidence from in vitro, Cellular, Experimental Animal and Human Studies
Georg Homuth et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2020)
3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
Grazia Rutigliano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway
Michael Rogowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment
Agostina Grillone et al.
NANOMEDICINE (2019)
Memantine prodrug as a new agent for Alzheimer's Disease
Simona Sestito et al.
SCIENTIFIC REPORTS (2019)
Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression
Fariba M. Assadi-Porter et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Central effects of 3-Iodothyronamine Reveal a novel Role for Mitochondrial Monoamine Oxidases
Annunziatina Laurino et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier
Iason Papademetriou et al.
PLOS ONE (2018)
The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice
Annunziatina Laurino et al.
HORMONES AND BEHAVIOR (2017)
Targeting the tight junction protein, zonula occludens-1, with the connexin43 mimetic peptide, αCT1, reduces VEGF-dependent RPE pathophysiology
Elisabeth Obert et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection
Lorenza Bellusci et al.
FRONTIERS IN PHARMACOLOGY (2017)
Thyronamines and Derivatives: Physiological Relevance, Pharmacological Actions, and Future Research Directions
Carolin Stephanie Hoefig et al.
THYROID (2016)
Evaluation of P-Glycoprotein Inhibitory Potential Using a Rhodamine 123 Accumulation Assay
Elodie Jouan et al.
PHARMACEUTICS (2016)
Microfluidic organ-on-chip technology for blood-brain barrier research
Marinke W. van der Helm et al.
TISSUE BARRIERS (2016)
The dynamic blood-brain barrier
James Keaney et al.
FEBS JOURNAL (2015)
The Blood-Brain Barrier
Richard Daneman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy
Famida G. Hoosain et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism
Claudia Musilli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
P-gp efflux pump inhibition potential of common environmental contaminants determined in vitro
Anastasia Georgantzopoulou et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2014)
Uptake and metabolic effects of 3-iodothyronamine in hepatocytes
Sandra Ghelardoni et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Modulation of Gene Expression by 3-Iodothyronamine: Genetic Evidence for a Lipolytic Pattern
Veronica Mariotti et al.
PLOS ONE (2014)
Update on 3-iodothyronannine and its neurological and metabolic actions
Riccardo Zucchi et al.
FRONTIERS IN PHYSIOLOGY (2014)
ATPase activity of nucleotide binding domains of human MDR3 in the context of MDR1
Masato Ishigami et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Paracellular Barrier and Tight Junction Protein Expression in the Immortalized Brain Endothelial Cell Lines bEND.3, bEND.5 and Mouse Brain Endothelial Cell 4
Takuya Watanabe et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold
Maria Elena Manni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice
Maria Elena Manni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors
Grazia Chiellini et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB)
Ross Booth et al.
LAB ON A CHIP (2012)
Thyronamines-Past, Present, and Future
S. Piehl et al.
ENDOCRINE REVIEWS (2011)
Effects of the thyroid hormone derivatives 3-iodothyronamine and thyronamine on rat liver oxidative capacity
P. Venditti et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)
Laura M. Hodges et al.
PHARMACOGENETICS AND GENOMICS (2011)
Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine
Alessandro Saba et al.
ENDOCRINOLOGY (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Thyronamines are isozyme-specific substrates of deiodinases
S. Piehl et al.
ENDOCRINOLOGY (2008)
Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function
Grazia Chiellini et al.
FASEB JOURNAL (2007)
Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells
Rachel C. Brown et al.
BRAIN RESEARCH (2007)
3-iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone
TS Scanlan et al.
NATURE MEDICINE (2004)
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities
DJ Begley
PHARMACOLOGY & THERAPEUTICS (2004)
Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies
Y Omidi et al.
BRAIN RESEARCH (2003)
Share Paper
